Results of Operations and Financial Condition · Regulation FD Disclosure
Item 2.02 Results of Operations and Financial Condition. On January 20, 2026, electroCore, Inc. (the “Company”) issued a press release providing a business update, including select unaudited preliminary financial guidance for the three and 12 months ended December 31, 2025. A copy of the press release is filed herewith as Exhibit 99.1.…
Filed Jan 20, 2026Accepted Jan 20, 2026, 4:05 PM ESTCIK 1560258Accession 0001493152-26-002847
electroCore, Inc. and its subsidiaries are a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. For more information, visit www.electrocore.com.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 2.02Item 2.02 - Results of Operations
Item
2.02 Results of Operations and Financial Condition.
On
January 20, 2026, electroCore, Inc. (the “Company”) issued a press release providing a business update, including select
unaudited preliminary financial guidance for the three and 12 months ended December 31, 2025. A copy of the press release is filed herewith
as Exhibit 99.1.
Additionally,
the executive officers of the Company have several upcoming presentations to representatives of investors and analysts. The presentation
includes the select unaudited preliminary financial estimates for the three and 12 months ended December 31, 2025. The officers intend
to use the material filed as Exhibit 99.2 herewith, in whole or in part, as part of those presentations.
The
selected financial results in Exhibits 99.1 and 99.2 are based on preliminary unaudited information and management estimates, are not
a comprehensive statement of the Company’s financial results for either the fourth quarter or fiscal year ended December 31, 2025
and are subject to change. Such changes may be material. Our independent registered public accounting firm has not conducted an audit
or review of and does not express an opinion or provide any other form of assurance with respect to, these preliminary results.
The
information furnished in this Item 2.02 of this Current Report on Form 8-K, Exhibit 99.1, and Exhibit 99.2, each attached hereto, shall
not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in
this Item 2.02 of this Current Report on Form 8-K, Exhibit 99.1, and Exhibit 99.2, shall not be incorporated by reference into any filing
with the Securities and Exchange Commission (the “SEC”) made by the Company, whether made before or after the date hereof,
except as shall be expressly set forth by reference in such filing.
The
financial information set forth in this Current Report on Form 8-K, Exhibit 99.1, and Exhibit 99.2 reflects the Company’s current
preliminary financial estimates, is subject to the completion of its audit process, and is subject to change. The Company’s fourth
quarter and full year ended December 31, 2025 results could differ materially from the preliminary estimates provided in this Current
Report on Form 8-K. Investors are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s
estimates only as of the date of this Current Report on Form 8-K. Investors should refer to the “Risk Factors” section of
the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 12, 2025, as updated and supplemented
by its other SEC reports filed from time to time, for a discussion of important factors that may cause actual results to differ materially
from those expressed or implied by these forward-looking statements. Given these risks, uncertainties and other factors, many of which
are beyond the Company’s control, investors are cautioned not to place undue reliance on these forward-looking statements. The
Company undertakes no obligation to publicly release the results of any revision or update of the forward-looking statements, except
as required by law.
Item
7.01. Regulation FD Disclosure.
The
information set forth under Item 2.02, “Results of Operations and Financial Condition,” is incorporated herein by reference.
Filed exhibits (2)
EX-99.1 (by filename) ex99-1.htm
Exhibit
99.1
electroCore
Provides Preliminary Full-Year 2025 Business Update;
Expects
~26% Revenue Growth to ~$31.8 - $32.0 Million
Record
revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0
- $9.2 million for the three months ended December 31, 2025
Revenue
growth of approximately 26% over full-year 2024
Cash,
cash equivalents, and marketable securities (“Total Cash”) balance of approximately
$11.6 million as of December 31, 2025
ROCKAWAY,
N.J., January 20, 2026 (GLOBE NEWSWIRE) - electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”),
a bioelectronic technology company, today provided select unaudited preliminary financial guidance for the full year and fourth quarter
of 2025.
Financial
Guidance
Preliminary
unaudited financial guidance for the full year and fourth quarter of 2025:
Revenue: The Company anticipates reporting record full year 2025 revenue of approximately $31.8 - $32.0 million. This would represent approximately
26% growth over full-year 2024 revenue of $25.2 million. Fourth quarter 2025 revenue is anticipated to be approximately $9.0 - $9.2 million,
which would represent approximately 30% growth…